Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 316.83B | 276.08B | 252.71B | 226.34B | 213.00B |
Gross Profit | 68.40B | 63.87B | 57.91B | 51.63B | 40.28B |
EBITDA | 62.06B | 58.88B | 56.66B | 55.50B | 43.00B |
Net Income | 19.93B | 19.83B | 18.85B | 15.67B | 9.71B |
Balance Sheet | |||||
Total Assets | 312.44B | 273.71B | 246.19B | 231.81B | 220.78B |
Cash, Cash Equivalents and Short-Term Investments | 32.53B | 45.47B | 44.39B | 48.69B | 44.44B |
Total Debt | 33.62B | 30.18B | 20.43B | 21.87B | 25.56B |
Total Liabilities | 170.35B | 146.68B | 126.89B | 127.18B | 129.81B |
Stockholders Equity | 140.68B | 125.75B | 118.12B | 103.53B | 89.96B |
Cash Flow | |||||
Free Cash Flow | 16.62B | 21.84B | 21.27B | 32.05B | 29.54B |
Operating Cash Flow | 28.53B | 40.78B | 38.53B | 43.57B | 40.54B |
Investing Cash Flow | -21.75B | -17.93B | -18.39B | -11.84B | -13.22B |
Financing Cash Flow | -19.67B | -20.80B | -25.73B | -27.30B | -23.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥19.26B | 11.74 | 3.46% | 6.35% | 3.10% | ||
78 Outperform | ¥9.76T | 15.19 | 13.28% | 4.09% | 2.66% | 11.83% | |
73 Outperform | $525.92B | 25.36 | 15.20% | 1.19% | 12.19% | 4.12% | |
69 Neutral | ¥10.57B | 43.73 | 1.20% | 1.95% | -59.39% | ||
69 Neutral | ¥27.53B | 30.07 | ― | 27.43% | -5.71% | ||
67 Neutral | ¥397.26B | 24.13 | 19.00% | 1.37% | 6.94% | 7.61% | |
66 Neutral | ¥486.96B | 16.60 | 1.07% | 2.20% | 6.20% | -17.02% |